Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition
Authors:
- Rossella BasilottaRBRossella Basilotta
- Marika LanzaMLMarika Lanza
- Alessia FilipponeAlessia Filippone
- Giovanna CasiliGCGiovanna Casili
- Deborah ManninoDMDeborah Mannino
- Federica De GaetanoFederica De Gaetano
- Giulia ChisariGCGiulia Chisari
- Lorenzo ColarossiLCLorenzo Colarossi
- Gianmarco MottaGMGianmarco Motta
- Michela CampoloMichela Campolo
- Salvatore CuzzocreaSalvatore Cuzzocrea
- Irene PaternitiIPIrene Paterniti
Open Access
- 1 February 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 2777
Abstract
Oral squamous cell carcinoma (OSCC) is a common human tumor, that originates from buccal mucosa and the tongue, associated with a high mortality rate. Currently, the treatment for OSCC involves surgery, chemotherapy and radiotherapy; however, survival outcomes for OSCC patients remain poor. For this reason, it is necessary to investigate new therapeutic strategies to counteract the progression of OSCC. In this study, we aimed to evaluate the role of dimethyl fumarate (DMF) in modulation of OSCC progression, both in vitro and in an in vivo orthotopic xenograft model. In vitro results revealed that DMF was able to reduce the expression of anti-apoptotic factors as BCL-2 and increased the expression of pro-apoptotic factors as Bax, Caspase-3 and BID. DMF appears to be involved in the modulation of oxidative stress mediators, such as MnSOD and HO-1. Furthermore, DMF showed to reduce the migratory ability of tumor cells and to modulate the expression of markers of epithelial-mesenchymal transition (EMT), as N-cadherin and E-cadherin. The in vivo study confirmed the data obtained in vitro significantly decreasing tumor mass and also reducing oxidative stress and apoptosis. Therefore, based on these results, the use of DMF could be considered a promising strategy to counteract oral cancer progression.Keywords
This publication has 32 references indexed in Scilit:
- Human papillomavirus and oral squamous cell carcinoma: A review of HPV-positive oral squamous cell carcinoma and possible strategies for futureCurrent Problems in Cancer, 2017
- Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts.2015
- Snail interacts with Id2 in the regulation of TNF-α-induced cancer cell invasion and migration in OSCC.2015
- Dimethyl fumarate for treating relapsing multiple sclerosisExpert Opinion on Drug Safety, 2014
- Dimethyl fumarate induces apoptosis of hematopoietic tumor cells via inhibition of NF-κB nuclear translocation and down-regulation of Bcl-xL and XIAPBiomedicine & Pharmacotherapy, 2014
- BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safetyCurrent Medical Research and Opinion, 2013
- Caspase Functions in Cell Death and DiseaseCold Spring Harbor Perspectives in Biology, 2013
- Dimethylfumarate inhibits tumor cell invasion and metastasis by suppressing the expression and activities of matrix metalloproteinases in melanoma cellsCell Biology International, 2009
- Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell linesBiochemical Pharmacology, 2007
- In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitroNature Protocols, 2007